Grace Capital’s iShares Biotechnology ETF IBB Stock Holding History

Grace Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-50	Closed	-$6K	–	259
2020 Q3	$6K	Sell	50 -700	-93%	-$95K	﹤0.01%	237
2020 Q2	$103K	Hold	750	–	–	0.09%	158
2020 Q1	$81K	Hold	750	–	–	0.08%	133
2019 Q4	$90K	Hold	750	–	–	0.07%	147
2019 Q3	$75K	Hold	750	–	–	0.08%	124
2019 Q2	$82K	Hold	750	–	–	0.04%	167
2019 Q1	$84K	Hold	750	–	–	0.03%	188
2018 Q4	$72K	Buy	+750	New	+$79.6K	0.03%	197

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Grace Capital's IBB Position: Q4 2020 in Review

Grace Capital sold out of iShares Biotechnology ETF (IBB) in Q4 2020, closing a stake of 50 shares — an estimated $6K sold.

Grace Capital first reported a position in IBB in Q4 2018 and held it in 8 quarters. The position peaked at $103K in Q2 2020. 856 funds tracked by Wall St. Rank hold IBB as of Q4 2020.

Grace Capital reported no remaining iShares Biotechnology ETF position as of Q4 2020 after selling out during the quarter.
Grace Capital sold 50 iShares Biotechnology ETF shares in Q4 2020, an estimated $6K.
Grace Capital first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 8 quarters.
Grace Capital's iShares Biotechnology ETF position peaked at $103K in Q2 2020.
856 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2020.

Based on Grace Capital's 13F filing for Q4 2020, filed 10 Feb 2021.